Company Filing History:
Years Active: 1996-1998
Title: Frances M Eckenrode: Innovator in Genetic Engineering
Introduction
Frances M Eckenrode is a notable inventor based in Kalamazoo, MI (US), recognized for her contributions to genetic engineering. With a total of two patents, her work has significantly impacted the field of recombinant methods and gene expression.
Latest Patents
Eckenrode's latest patents include an expression vector containing the PL6M promoter and TAT32 ribosome binding site. This invention provides expression vectors that facilitate the expression of exogenous genes in E. coli. The disclosed expression vector comprises essential elements in operable linkage, including the PL6M promoter, the TAT32 ribosome binding site, and a gene encoding a heterologous polypeptide. Additionally, her work includes a patent focused on eliminating internal initiation of the soluble CD4 gene. This invention addresses the discovery that proteins made from genes containing the CD4 sequence in their cDNA can produce additional polypeptides due to internal translation initiation.
Career Highlights
Throughout her career, Frances M Eckenrode has worked with prominent companies such as The Upjohn Company and Pharmacia & Upjohn Company. Her experience in these organizations has contributed to her expertise in the field of genetic engineering.
Collaborations
Eckenrode has collaborated with notable colleagues, including Richard J Kirschner and John E Mott. These partnerships have further enhanced her research and development efforts.
Conclusion
Frances M Eckenrode's innovative work in genetic engineering and her patents reflect her significant contributions to the field. Her collaborations and career experiences have positioned her as a key figure in advancing recombinant methods and gene expression technologies.